更新于 2月3日
职位描述
生物药药理学
岗位职责:
1.Monitor and manage non-clinical ADME-PK studies and integrated drug discovery to development programs
2.Communicate proactively with clients and propose ADME-PK study designs/program strategies to address key technical issues or potential risks
3.Work as a study director on each study including but not limited to below list,
Prepare high quality study protocol/design
Lead the internal meeting for scientific discussion and share study information clearly and in time
Oversee data collection, interpretation, analysis, documentation and results reporting
Deliver feedback and report to clients in a timely manner and maintain good relationship with existing clients
4.Work directly with all levels of management to address key technology information or lead scientific discussion cross-functional teams/departments
5.Be able to consolidate in vitro/in vivo data, and present in DMPK program review. Invite advices and advocate scientific discussions as needed
6.Work with sales/marketing team on business development
任职要求:
1.Majored in Pharmacokinetics, Pharmaceutical Science, Analytical Science, Pharmacology, Medicinal Chemistry or other related fields, Ph.D. is preferred
2.More than 5 years experiences in contract research organization, academia, or pharmaceutical industry is preferred
3.Fluent in both English and Chinese (verbal and written)
4.Excellent skills on communication
工作地点
苏州市吴中区吴中大道1318号
公司信息
苏州药明康德新药开发有限公司
已上市 · 100-299人 · 医药制造
已审核
公司介绍
药明康德（股票代码：603259.SH/2359.HK）是国际领先的开放式能力与技术平台公司，为全球制药及医疗器械等领域提供从药物发现、开发到市场化的全方位一体化的实验室研发和生产服务。本着以研究为首任，以客户为中心的宗旨，药明康德通过高性价比、高效率的服务平台帮助全球客户缩短药物及医疗器械研发周期、降低研发成本。药明康德平台涵括化学药研发和生产、细胞及基因疗法研发生产、药物研发和医疗器械测试等，正承载着来自全球30多个国家的3500多家创新合作伙伴的数千个研发创新项目，致力于将最新和最好的医药和健康产品带给全球病患，实现“让天下没有难做的药，难治的病”的梦想。
工商信息
企业名称 苏州药明康德新药开发有限公司
企业类型 有限责任公司
法人代表 张朝晖
经营状态 存续
成立时间 2006-10-08
注册资本 10.5亿元
认证资质
营业执照信息